Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA advisory panel recommends Apligraf

Feb. 3, 1998

Vitamin D3 analogues from Roche for skin, neoplastic diseases

Feb. 2, 1998

Vitamin D analogues disclosed by Roche for hyperproliferative disorders

Jan. 30, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Once-daily hair loss treatment available throughout the U.S.

Jan. 27, 1998

Expansion of Advanced Tissues Sciences/Smith & Nephew joint venture planned

Jan. 26, 1998

Laminin-related polypeptides from the University of Minnesota

Jan. 26, 1998

Lexacalcitol: a vitamin D analogue with increased potency

Jan. 23, 1998

Connetics to develop clobetasol mousse for dermatoses

Jan. 16, 1998

Genzyme General discontinues U.S. development of Sepracoat

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...